Cue Biopharma (CUE) Other Non-Current Assets (2017 - 2025)

Cue Biopharma has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $94000.0 for Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $94000.0, down 10.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $94000.0 (down 10.48% YoY), and the FY2025 annual result was $94000.0, down 10.48% from the prior year.
• Other Non-Current Assets came in at $94000.0 for Q4 2025 at Cue Biopharma, down from $153000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.0 million in Q1 2023 to a low of $94000.0 in Q4 2025.
• The 5-year median for Other Non-Current Assets is $150500.0 (2021), against an average of $674800.0.
• Across the five-year window, Other Non-Current Assets soared 2121.64% in 2023 and slumped 94.93% in 2024, its largest moves.
• Cue Biopharma's Other Non-Current Assets stood at $150000.0 in 2021, then changed by 0.0% to $150000.0 in 2022, then dropped by 22.0% to $117000.0 in 2023, then retreated by 10.26% to $105000.0 in 2024, then fell by 10.48% to $94000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $94000.0 (Q4 2025), $153000.0 (Q3 2025), and $153000.0 (Q2 2025), per Business Quant data.